January 1993
Volume 34, Issue 1
Free
Articles  |   January 1993
The effects of acetazolamide on visual function in retinitis pigmentosa.
Author Affiliations
  • V C Greenstein
    Department of Ophthalmology, New York University Medical Center, New York 10016.
  • K Holopigian
    Department of Ophthalmology, New York University Medical Center, New York 10016.
  • E Siderides
    Department of Ophthalmology, New York University Medical Center, New York 10016.
  • W Seiple
    Department of Ophthalmology, New York University Medical Center, New York 10016.
  • R E Carr
    Department of Ophthalmology, New York University Medical Center, New York 10016.
Investigative Ophthalmology & Visual Science January 1993, Vol.34, 269-273. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      V C Greenstein, K Holopigian, E Siderides, W Seiple, R E Carr; The effects of acetazolamide on visual function in retinitis pigmentosa.. Invest. Ophthalmol. Vis. Sci. 1993;34(1):269-273.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

PURPOSE: To study the effects of acetazolamide on central and peripheral visual function in patients with retinitis pigmentosa (RP) who showed no evidence of macular edema. METHODS: Thirteen patients with retinitis pigmentosa participated in a preliminary study. Measures of central and peripheral visual function were obtained before and after an 8 wk period on acetazolamide. An additional 10 patients participated in a cross-over study. They were placed on a placebo for an 8 wk period, then on acetazolamide for a second 8 wk period. RESULTS: None of the patients in the preliminary study showed significant changes in visual acuity, color vision, foveal cone pathway sensitivities, focal electroretinogram (ERG) amplitudes, or in any ERG parameter. Three patients, however, showed significant changes in visual field area and in dark-adapted thresholds. None of the patients in the cross-over study showed significant increases in visual field area. CONCLUSIONS: Given the results and the reports of side-effects, it is difficult to justify using acetazolamide to improve retinal function in RP patients who show no evidence of cystoid macular edema.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×